Related Experiment Video
Updated: Feb 8, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Optimising drug therapy for non-infectious uveitis
Mohammad Ali Shahab1, Tahreem Aman Mir2, Sidra Zafar3
1Aga Khan University, Karachi, Pakistan. mohammadali.shahab.m11@student.aku.edu.
Introduction:
Uveitis encompasses a wide variety of sight-threatening diseases characterized by intraocular inflammation. It is often classified as infectious and non-infectious uveitis. Unlike infectious uveitis, a distinct infectious agent cannot be identified in non-infectious uveitis and disease origin is usually autoimmune, drug related, or idiopathic.
The Issue At Hand:
Non-infectious uveitis can often have a relapsing-remitting course, making it difficult to treat, and poses a significant challenge to ophthalmologists. The autoimmune nature of non-infectious uveitis warrants the use of anti-inflammatory and immunomodulatory agents for disease control. However, a subset of patients has persistent or recurrent ocular inflammation despite appropriate treatment, stressing the need for newer therapies aimed at more specific inflammatory targets such as tumour necrosis factor (TNF) alpha agents, anti-interleukin agents, and anti-interleukin receptor agents.
Objectives:
This article discusses the various medical options available for the treatment of non-infectious uveitis in the light of the most recent evidence.
Conclusion:
Successful management of non-infectious uveitis requires the clinician carefully balance advantages and disadvantages of each new and old therapy while considering individual circumstances. Counselling regarding the benefits and complications of each therapy can help patients make an informed choice.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Gene Therapy
Group Therapy

